Filters
Influenza infection appears to be a risk factor for systemic lupus erythematosus flares needing hospitalization, independently of patient age, sex, and comorbidities, a recent study has found.
The body is capable of mounting a humoral immune response with functional cross-reactivity against the D614G variant of SARS-CoV-2, claims a recent Singapore study.
Patients with severe asthma receiving treatment with biologics are more likely to contract COVID-19 and develop a severe course as compared with the general population, a study has found.
As the Hong Kong government launches a territory-wide coronavirus disease 2019 (COVID-19) vaccination programme, the Chinese University of Hong Kong (CUHK) and the University of Hong Kong (HKU) have shared findings of their independent telephone surveys gauging public views of the programme.
Around 2 percent of people seeking post-exposure prophylaxis (PEP) eventually test positive for HIV within 4 years, a recent study has found. This trend is particularly pronounced among men who have sex with men (MSM), strongly suggesting the potential for the early consideration of pre-exposure prophylaxis (PrEP) after a first episode of PEP.
Patients with the novel coronavirus disease (COVID-19) are prone to gastrointestinal (GI) symptoms, which appears to predict a better prognosis, suggests a single-centre cohort study in Northern Italy.
A recent modelling study has found that expanding current pre-exposure prophylaxis (PrEP) programmes and improving adherence rates can substantially lower HIV incidence among men who have sex with men (MSM).
While more and more COVID-19 vaccines are getting rolled out globally, the world is also seeing new variants of SARS-CoV-2 emerging. How effective will the vaccines work against these new variants is largely unknown. Billions worldwide are watching closely and bracing themselves on how this might unfold.
Being hospitalized for respiratory infections heightens the risk of myocardial infarction (MI) and venous thromboembolism (VTE), especially in the first 30 days after discharge, a recent study has found.
Critical or severe COVID-19 disease could raise the risk of negative perinatal outcomes in pregnant women, according to an observational study from the US.
